首页> 外文期刊>Archives of disease in childhood >Reduced levels of growth hormone, insulin-like growth factor-I and binding protein-3 in patients with shunted hydrocephalus.
【24h】

Reduced levels of growth hormone, insulin-like growth factor-I and binding protein-3 in patients with shunted hydrocephalus.

机译:分流性脑积水患者的生长激素,胰岛素样生长因子-I和结合蛋白-3水平降低。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVE: Children with hydrocephalus are characterised by slow linear growth in prepuberty, accelerated physical maturation during puberty, and reduced final height. We aimed to study the possible roles of growth hormone, insulin-like growth factor-I (IGF-I), and IGF binding protein-3 (IGFBP-3) in this growth pattern. STUDY DESIGN: One hundred and fourteen patients with shunted hydrocephalus (62 males) aged 5 to 20 years, of whom 17 had spina bifida (six males), and 73 healthy controls (38 males) were studied. Anthropometric measures, body mass index, and body fat mass were assessed and the stage of puberty was determined. Serum growth hormone and plasma IGF-I and IGFBP-3 concentrations were measured. RESULTS: The patients comprised 44 (26 males) who were prepubertal and 70 (36 males) pubertal or postpubertal, while 32 of the controls (19 males) were prepubertal and 41 (19 males) pubertal or postpubertal. The prepubertal children with hydrocephalus had lower IGF-I (p = 0.002) and IGFBP-3 concentrations (p < 0.001) than the controls, and the pubertal children had four times lower basal growth hormone concentrations (p < 0.001). There was a correlation between height SD score and IGF-I levels in the total patient population (r = 0.23; p = 0.01). Peripheral IGF-I concentrations peaked at pubertal stages 2-3 in the female patients and at stage 4 in the controls. The prepubertal patients on antiepileptic treatment, carbamazepine in most cases (73%), had higher IGF-I (p = 0.01) and IGFBP-3 concentrations (p = 0.03) than those who had never been treated with antiepileptic drugs, but still lower IGFBP-3 levels than the controls (p = 0.01). CONCLUSION: Based on these findings, it can be concluded that reduced growth hormone secretion may contribute to the pattern of slow linear growth and reduced final height observed in these patients.
机译:目的:脑积水患儿的特征是青春期前线性增长缓慢,青春期期间身体成熟加速,最终身高降低。我们旨在研究生长激素,胰岛素样生长因子-I(IGF-1)和IGF结合蛋白3(IGFBP-3)在这种生长方式中的可能作用。研究设计:研究了114例5至20岁的脑积水患者(62例男性),其中17例患有脊柱裂(6例男性),以及73例健康对照(38例男性)。评估人体测量指标,体重指数和体脂肪量,并确定青春期。测量血清生长激素和血浆IGF-1和IGFBP-3浓度。结果:患者包括44名(26名男性)青春期前和70名(36名男性)青春期或青春期,而对照组中的32名(19名男性)为青春期前和41名(19名男性)青春期或青春期。青春期前脑积水患儿的IGF-I(p = 0.002)和IGFBP-3浓度低于对照组(p <0.001),青春期患儿的基础生长激素浓度低四倍(p <0.001)。在总的患者人群中,身高SD评分与IGF-I水平之间存在相关性(r = 0.23; p = 0.01)。外周血IGF-I浓度在女性患者的青春期第2-3阶段和对照组的第4阶段达到峰值。接受抗癫痫治疗的青春期前患者(大多数情况下为卡马西平)(73%)比从未接受过抗癫痫药物治疗的患者具有更高的IGF-I(p = 0.01)和IGFBP-3浓度(p = 0.03),但仍更低IGFBP-3水平高于对照组(p = 0.01)。结论:基于这些发现,可以得出结论,在这些患者中观察到生长激素分泌减少可能是线性增长缓慢和最终身高降低的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号